Drug target · CNR2
CB2
Cannabinoid receptor 2
1 compound in the CNS pipeline acts on CB2.
Compounds targeting CB2
| Compound | Action | Affinity | Lead program | Developer |
|---|---|---|---|---|
| AP707Natural product | Partial agonist | — | Phase 3Neuropathic pain | Apurano Pharmaceuticals GmbH |